Chris Bahl is president, CEO and founder of the biotech company AI Proteins, where he leads a team designing next-generation miniproteins — compact, powerful molecules with vast potential in medicine, agriculture and beyond. Bahl’s team uses AI, synthetic biology and robotics to create breakthrough therapeutics, with a focus on oncology. He is a 2019 TED Fellow.
